Ravikumar Ponnusamy
Affiliations: | University of California, Los Angeles, Los Angeles, CA |
Area:
Fear memory extinctionGoogle:
"Ravikumar Ponnusamy"Mean distance: 13.75 (cluster 19) | S | N | B | C | P |
Parents
Sign in to add mentorMark Barad | post-doc | 2002-2004 | UCLA |
Michael Fanselow | research scientist | 2004- | UCLA |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ponnusamy R, McNerney W, Moghadam S, et al. (2017) Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer's disease. Brain Research |
Lin Q, Ponnusamy R, Widagdo J, et al. (2017) MicroRNA-mediated disruption of dendritogenesis during a critical period of development influences cognitive capacity later in life. Proceedings of the National Academy of Sciences of the United States of America |
Mojabi FS, Fahimi A, Moghadam S, et al. (2016) GABAergic Hyperinnervation of Dentate Granule Cells in the Ts65Dn Mouse Model of Down Syndrome Exploring the Role of App. Hippocampus |
Ponnusamy R, Zhuravka I, Poulos AM, et al. (2016) Retrieval and Reconsolidation Accounts of Fear Extinction. Frontiers in Behavioral Neuroscience. 10: 89 |
Tracy TE, Sohn PD, Minami SS, et al. (2016) Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss. Neuron |
Maeda S, Djukic B, Taneja P, et al. (2016) Expression of A152T human tau causes age-dependent neuronal dysfunction and loss in transgenic mice. Embo Reports |
Phillips C, Fahimi A, Das D, et al. (2015) Noradrenergic System in Down Syndrome and Alzheimer's Disease A Target for Therapy. Current Alzheimer Research |
Das D, Medina B, Baktir MA, et al. (2015) Increased incidence of intermittent hypoxemia in the Ts65Dn mouse model of Down syndrome. Neuroscience Letters. 604: 91-6 |
Cheng JS, Craft R, Yu GQ, et al. (2014) Tau reduction diminishes spatial learning and memory deficits after mild repetitive traumatic brain injury in mice. Plos One. 9: e115765 |
Lee EK, Hu C, Bhargava R, et al. (2013) AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse. Gene Therapy. 20: 785-96 |